Cart
sales@molnova.com
Home - Products - Others - Other Targets - Apcin A HCL

Apcin A HCL

CAS No. 1683535-53-6

Apcin A HCL( —— )

Catalog No. M26003 CAS No. 1683535-53-6

Apcin A HCL is an Apcin derivative. Apcin A HCL is an anaphase-promoting complex (APC) inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 302 In Stock
10MG 444 In Stock
25MG 711 In Stock
50MG 1008 In Stock
100MG 1341 In Stock
500MG 2673 In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    Apcin A HCL
  • Note
    Research use only, not for human use.
  • Brief Description
    Apcin A HCL is an Apcin derivative. Apcin A HCL is an anaphase-promoting complex (APC) inhibitor.
  • Description
    Apcin A HCL is an Apcin derivative. Apcin A HCL is an anaphase-promoting complex (APC) inhibitor. Apcin-A HCL interacts strongly with Cdc20, and inhibits the ubiquitination of Cdc20 substrates. Apcin-A HCL can be used to synthesize the PROTAC CP5V.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    5-HT Receptor| Dopamine| GABA Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1683535-53-6
  • Formula Weight
    379.07
  • Molecular Formula
    C10H15Cl4N5O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(OCCCN)NC(NC1=NC=CC=N1)C(Cl)(Cl)Cl.[H]Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.?Lei Deng, et al. Sedative-hypnotic and Anxiolytic Effects and the Mechanism of Action of Aqueous Extracts of Peanut Stems and Leaves in Mice. J Sci Food Agric. 2018 Oct;98(13):4885-4894.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • H-ASP-PHE-OH

    Used as pharmaceutical intermediates.

  • Remimazolam

    Remimazolam is a benzodiazepine derivative drug as an alternative to the short-acting imidazobenzodiazepine midazolam, for use in induction of anaesthesia and conscious sedation for minor invasive procedures.?Remimazolam was found to be both faster acting and shorter lasting than midazolam, and human clinical trials showed a faster recovery time and predictable, consistent pharmacokinetics, suggesting some advantages over existing drugs for these applications.?

  • DHAPC

    DHAPC (1,2-Didocosahexaenoyl-sn-glycero-3-phosphocholine) can be used as a fluorine-18 radiolabeling agent for PET imaging of prostate cancer.

Sign In Join Free